Peptide drugs have become a research hotspot in the pharmaceutical field due to their high targeting and low side effects. Retatrutide, as a triple receptor agonist for GIP/GLP-1/GCGR, has continuously made breakthroughs in metabolic disease research in recent years. The latest clinical data show that its effects in weight management and blood sugar regulation provide […]
